2024-04-012025-03-312025-03-31false11232871NORTHBOURNE PRACTICE LTD2025-12-1286230falseiso4217:GBPxbrli:pure112328712024-03-31112328712025-03-31112328712024-04-012025-03-31112328712023-03-31112328712024-03-31112328712023-04-012024-03-3111232871bus:SmallEntities2024-04-012025-03-3111232871bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3111232871bus:FullAccounts2024-04-012025-03-3111232871bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111232871core:WithinOneYear2025-03-3111232871core:AfterOneYear2025-03-3111232871core:WithinOneYear2024-03-3111232871core:AfterOneYear2024-03-3111232871core:ShareCapital2025-03-3111232871core:SharePremium2025-03-3111232871core:RevaluationReserve2025-03-3111232871core:OtherReservesSubtotal2025-03-3111232871core:RetainedEarningsAccumulatedLosses2025-03-3111232871core:ShareCapital2024-03-3111232871core:SharePremium2024-03-3111232871core:RevaluationReserve2024-03-3111232871core:OtherReservesSubtotal2024-03-3111232871core:RetainedEarningsAccumulatedLosses2024-03-3111232871core:LandBuildings2025-03-3111232871core:PlantMachinery2025-03-3111232871core:Vehicles2025-03-3111232871core:FurnitureFittings2025-03-3111232871core:OfficeEquipment2025-03-3111232871core:NetGoodwill2025-03-3111232871core:IntangibleAssetsOtherThanGoodwill2025-03-3111232871core:ListedExchangeTraded2025-03-3111232871core:UnlistedNon-exchangeTraded2025-03-3111232871core:LandBuildings2024-03-3111232871core:PlantMachinery2024-03-3111232871core:Vehicles2024-03-3111232871core:FurnitureFittings2024-03-3111232871core:OfficeEquipment2024-03-3111232871core:NetGoodwill2024-03-3111232871core:IntangibleAssetsOtherThanGoodwill2024-03-3111232871core:ListedExchangeTraded2024-03-3111232871core:UnlistedNon-exchangeTraded2024-03-3111232871core:LandBuildings2024-04-012025-03-3111232871core:PlantMachinery2024-04-012025-03-3111232871core:Vehicles2024-04-012025-03-3111232871core:FurnitureFittings2024-04-012025-03-3111232871core:OfficeEquipment2024-04-012025-03-3111232871core:NetGoodwill2024-04-012025-03-3111232871core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111232871core:ListedExchangeTraded2024-04-012025-03-3111232871core:UnlistedNon-exchangeTraded2024-04-012025-03-3111232871core:MoreThanFiveYears2024-04-012025-03-3111232871core:Non-currentFinancialInstruments2025-03-3111232871core:Non-currentFinancialInstruments2024-03-3111232871dpl:CostSales2024-04-012025-03-3111232871dpl:DistributionCosts2024-04-012025-03-3111232871core:LandBuildings2024-04-012025-03-3111232871core:PlantMachinery2024-04-012025-03-3111232871core:Vehicles2024-04-012025-03-3111232871core:FurnitureFittings2024-04-012025-03-3111232871core:OfficeEquipment2024-04-012025-03-3111232871dpl:AdministrativeExpenses2024-04-012025-03-3111232871core:NetGoodwill2024-04-012025-03-3111232871core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111232871dpl:GroupUndertakings2024-04-012025-03-3111232871dpl:ParticipatingInterests2024-04-012025-03-3111232871dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3111232871core:ListedExchangeTraded2024-04-012025-03-3111232871dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3111232871core:UnlistedNon-exchangeTraded2024-04-012025-03-3111232871dpl:CostSales2023-04-012024-03-3111232871dpl:DistributionCosts2023-04-012024-03-3111232871core:LandBuildings2023-04-012024-03-3111232871core:PlantMachinery2023-04-012024-03-3111232871core:Vehicles2023-04-012024-03-3111232871core:FurnitureFittings2023-04-012024-03-3111232871core:OfficeEquipment2023-04-012024-03-3111232871dpl:AdministrativeExpenses2023-04-012024-03-3111232871core:NetGoodwill2023-04-012024-03-3111232871core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111232871dpl:GroupUndertakings2023-04-012024-03-3111232871dpl:ParticipatingInterests2023-04-012024-03-3111232871dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3111232871core:ListedExchangeTraded2023-04-012024-03-3111232871dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3111232871core:UnlistedNon-exchangeTraded2023-04-012024-03-3111232871core:NetGoodwill2025-03-3111232871core:IntangibleAssetsOtherThanGoodwill2025-03-3111232871core:LandBuildings2025-03-3111232871core:PlantMachinery2025-03-3111232871core:Vehicles2025-03-3111232871core:FurnitureFittings2025-03-3111232871core:OfficeEquipment2025-03-3111232871core:AfterOneYear2025-03-3111232871core:WithinOneYear2025-03-3111232871core:ListedExchangeTraded2025-03-3111232871core:UnlistedNon-exchangeTraded2025-03-3111232871core:ShareCapital2025-03-3111232871core:SharePremium2025-03-3111232871core:RevaluationReserve2025-03-3111232871core:OtherReservesSubtotal2025-03-3111232871core:RetainedEarningsAccumulatedLosses2025-03-3111232871core:NetGoodwill2024-03-3111232871core:IntangibleAssetsOtherThanGoodwill2024-03-3111232871core:LandBuildings2024-03-3111232871core:PlantMachinery2024-03-3111232871core:Vehicles2024-03-3111232871core:FurnitureFittings2024-03-3111232871core:OfficeEquipment2024-03-3111232871core:AfterOneYear2024-03-3111232871core:WithinOneYear2024-03-3111232871core:ListedExchangeTraded2024-03-3111232871core:UnlistedNon-exchangeTraded2024-03-3111232871core:ShareCapital2024-03-3111232871core:SharePremium2024-03-3111232871core:RevaluationReserve2024-03-3111232871core:OtherReservesSubtotal2024-03-3111232871core:RetainedEarningsAccumulatedLosses2024-03-3111232871core:NetGoodwill2023-03-3111232871core:IntangibleAssetsOtherThanGoodwill2023-03-3111232871core:LandBuildings2023-03-3111232871core:PlantMachinery2023-03-3111232871core:Vehicles2023-03-3111232871core:FurnitureFittings2023-03-3111232871core:OfficeEquipment2023-03-3111232871core:AfterOneYear2023-03-3111232871core:WithinOneYear2023-03-3111232871core:ListedExchangeTraded2023-03-3111232871core:UnlistedNon-exchangeTraded2023-03-3111232871core:ShareCapital2023-03-3111232871core:SharePremium2023-03-3111232871core:RevaluationReserve2023-03-3111232871core:OtherReservesSubtotal2023-03-3111232871core:RetainedEarningsAccumulatedLosses2023-03-3111232871core:AfterOneYear2024-04-012025-03-3111232871core:WithinOneYear2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111232871core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3111232871core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3111232871core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3111232871core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3111232871core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3111232871core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3111232871core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3111232871core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3111232871core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3111232871core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3111232871core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3111232871bus:Director12024-04-012025-03-3111232871bus:Director22024-04-012025-03-3111232871core:FurnitureFittingsToolsEquipment2024-03-3111232871core:FurnitureFittingsToolsEquipment2024-04-012025-03-3111232871core:FurnitureFittingsToolsEquipment2025-03-31

NORTHBOURNE PRACTICE LTD

Registered Number
11232871
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

NORTHBOURNE PRACTICE LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

ALLOUB, Yasmin, Dr
PATEL, Dilen Surendrakumar, Dr

Registered Address

Falcon Garage
Burghfield Road
Tadley
RG26 4QY

Registered Number

11232871 (England and Wales)
NORTHBOURNE PRACTICE LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3173,594199,892
Tangible assets4445,792479,282
619,386679,174
Current assets
Stocks53,4112,384
Debtors629,29232,785
Cash at bank and on hand32,73122,418
65,43457,587
Creditors amounts falling due within one year7(395,725)(461,528)
Net current assets (liabilities)(330,291)(403,941)
Total assets less current liabilities289,095275,233
Creditors amounts falling due after one year8(189,104)(212,829)
Provisions for liabilities9(29,588)(44,209)
Net assets70,40318,195
Capital and reserves
Called up share capital100100
Profit and loss account70,30318,095
Shareholders' funds70,40318,195
The financial statements were approved and authorised for issue by the Board of Directors on 12 December 2025, and are signed on its behalf by:
ALLOUB, Yasmin, Dr
Director
PATEL, Dilen Surendrakumar, Dr
Director

Registered Company No. 11232871
NORTHBOURNE PRACTICE LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Goodwill, being the amount paid in connection with the acquisition of businesses is being amortised evenly over its estimated useful life of 10 years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings-50
Fixtures and fittings20-
Vehicles20-
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Financial instruments
Financial assets and liabilities are offset, with the net amounts presented in the financialstatements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortized cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year66
3.Intangible assets

Goodwill

Other

Total

£££
Cost or valuation
At 01 April 24261,6641,320262,984
At 31 March 25261,6641,320262,984
Amortisation and impairment
At 01 April 2462,9989463,092
Charge for year26,16713126,298
At 31 March 2589,16522589,390
Net book value
At 31 March 25172,4991,095173,594
At 31 March 24198,6661,226199,892
4.Tangible fixed assets

Land & buildings

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 24332,106257,18599,545688,836
Additions4,1412,5414947,176
At 31 March 25336,247259,726100,039696,012
Depreciation and impairment
At 01 April 2420,425166,02623,103209,554
Charge for year6,72518,57615,36540,666
At 31 March 2527,150184,60238,468250,220
Net book value
At 31 March 25309,09775,12461,571445,792
At 31 March 24311,68191,15976,442479,282
Land and buildings includes improvment of £131,989.
5.Stocks

2025

2024

££
Other stocks3,4112,384
Total3,4112,384
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables14,53118,168
Amounts owed by group undertakings10,04510,045
Other debtors4242
Prepayments and accrued income4,6744,530
Total29,29232,785
Other debtor of £42.08 (2024 ; £42.08) related to Optimum Vision Clinic.
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables15,66033,808
Bank borrowings and overdrafts21,18218,709
Amounts owed to related parties277,144328,011
Other creditors78,73977,999
Accrued liabilities and deferred income3,0003,001
Total395,725461,528
8.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts189,104212,829
Total189,104212,829
Included within creditors falling due within one year and creditors falling due after one year is £ 210,286 (2024: £231,538) in respect of a Lloyds Business Loan and and Commercial Mortgage loan. This loan is secured by a fixed and floating charge over present and future assets of the company.
9.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)29,58844,209
Total29,58844,209
10.Directors advances, credits and guarantees
As at year end director balance of NIL (2024 : £360 Cr.) related to Dilen Patel and NIL (2024 : £417 Cr.) related to Yasmin Alloub.
11.Related party transactions
Debtors includes £10,045 (2024 : £10,045) due from Alder Road Practice Ltd. Other creditors include £277,011 (2024 : £328,011) amount due to Exate Ltd and £133.26 (2024 : NIL) amount due to Victoria Road Practice.